| Drug Type CAR-T | 
| Synonyms- | 
| Target | 
| Action modulators | 
| Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD22 modulators(CD22 modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1/2 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| B-Cell Leukemia | Phase 2 | China  | 20 Jan 2025 | |
| Diffuse Large B-Cell Lymphoma | Phase 2 | China  | 20 Jan 2025 | 





